Morteau O, Julia V, Eeckhout C, Bueno L
Department of Pharmacology, INRA, Toulouse, France.
Fundam Clin Pharmacol. 1994;8(6):553-62. doi: 10.1111/j.1472-8206.1994.tb00837.x.
We investigated the possible involvement of 5-HT3 receptors in the colonic motor alterations and abdominal pain evoked by rectal distension (RD) in rats, under normal and inflammatory conditions. Responses to RD were evaluated by electromyography in rats treated with 5-HT3 antagonists (ondansetron and cilansetron, 0.1 and 1 mg/kg, intraperitoneally), before and 3 days after intrarectal administration of TNB/ethanol. RD evoked a significant (P < 0.05) and gradual inhibition of the occurrence of colonic spike bursts (SB) and a gradual increase in abdominal SB from 11 mm in diameter on wards. Ondansetron and cilansetron (0.1 mg/kg) significantly reduced both the colonic (62 and 66%, respectively) and the abdominal response (28 and 61%, respectively) for an 11 mm diameter of RD. After TNB/ethanol, both colonic and abdominal responses to RD were significantly (P < 0.05) enhanced and appeared for a lower diameter (9 mm) (colon: 4.8 +/- 0.9 vs 8.4 +/- 1.1, abdomen: 7.7 +/- 1.5 vs 0.5 +/- 0.4). Cilansetron (0.1, 1 mg/kg) significantly (P < 0.05) attenuated the TNB-induced colonic motor inhibition, while ondansetron and cilansetron (0.1, 1 mg/kg) reduced the TNB-induced increase in abdominal response. We conclude that 5-HT and 5-HT3 receptors mediate RD-induced viscerosensitive alterations in rats, both in normal conditions and during TNB-induced rectocolitis. However, the relative efficacy of the 5-HT3 receptor antagonists depends on the experimental conditions (intact or inflamed bowel) and does not appear to increase with the dose.
我们研究了5-羟色胺3(5-HT3)受体在正常和炎症条件下,是否参与大鼠直肠扩张(RD)诱发的结肠运动改变和腹痛。通过肌电图评估5-HT3拮抗剂(昂丹司琼和西兰司琼,腹腔注射,剂量分别为0.1和1毫克/千克)处理的大鼠在直肠内注射三硝基苯磺酸(TNB)/乙醇前及注射后3天对RD的反应。RD引起结肠峰电位爆发(SB)发生率显著(P<0.05)且逐渐受到抑制,腹部SB从直径11毫米起逐渐增加。对于直径11毫米的RD,昂丹司琼和西兰司琼(0.1毫克/千克)分别显著降低结肠反应(分别为62%和66%)和腹部反应(分别为28%和61%)。TNB/乙醇处理后,结肠和腹部对RD的反应均显著(P<0.05)增强,且在较小直径(9毫米)时出现(结肠:4.8±0.9对8.4±1.1,腹部:7.7±1.5对0.5±0.4)。西兰司琼(0.1、1毫克/千克)显著(P<0.05)减轻TNB诱导的结肠运动抑制,而昂丹司琼和西兰司琼(0.1、1毫克/千克)降低TNB诱导的腹部反应增加。我们得出结论,5-羟色胺(5-HT)和5-HT3受体在正常条件下以及TNB诱导的直肠结肠炎期间均介导大鼠RD诱发的内脏敏感性改变。然而,5-HT3受体拮抗剂的相对疗效取决于实验条件(肠完整或发炎),且似乎并不随剂量增加而提高。